Strattera (atomoxetine) vs Qelbree

MEDICATION COMPARISON · FROM FDA LABELS AND HEAD-TO-HEAD STUDIES

Reviewed by Tariq Halim, MD · Last medical review: October 29, 2026 · Editorial policy

Strattera (atomoxetine) and Qelbree are both FDA-approved ADHD medicines. Strattera (atomoxetine) contains atomoxetine and Qelbree contains viloxazine. No head-to-head trial compares them, so this page compares label facts only and does not rank them. Facts below come from each product’s FDA label.

Side-by-side facts (from each FDA label)

Each cell is copied from that product’s key facts, which cite its current FDA prescribing information. Durations and doses come from each product’s own label studies; they are not a head-to-head comparison.

Strattera (atomoxetine)Qelbree
Drug classSelective Norepinephrine Reuptake Inhibitor · NonstimulantsSelective Norepinephrine Reuptake Inhibitor · Nonstimulants
Active ingredientatomoxetineviloxazine
FDA-approved ages6 years and older, and adults6 years and older, and adults
Form and strengthsCapsule; Capsule strengths: 10, 18, 25, 40, 60, 80, 100 mg (generic atomoxetine; Strattera brand discontinued); Oral solution: Atoncy 4 mg/mL, 100 mL bottle with 10 mL oral syringe (approved March 2026)Extended-release capsule; 100 mg, 150 mg, 200 mg extended-release capsules
Usual dose and maximum (label)Under 70 kg: start 0.5 mg/kg/day, target 1.2 mg/kg/day; 70 kg or more and adults: start 40 mg/day, target 80 mg/day, maximum 100 mg/day.Start 100 mg (ages 6–11) or 200 mg (12–17 and adults) once daily; maximum 400 mg (6–17) or 600 mg (adults).
Duration (label)Taken every day; the labels do not describe an hour-by-hour effect (benefit measured after weeks of treatment).Taken once daily, every day; the label does not describe hour-by-hour effects (benefit measured after 6–8 weeks).
DEA scheduleNot a controlled substanceNot a controlled substance
GenericAB-rated generics (see Generic manufacturers)No generic (see Generic manufacturers)
Label datePrescribing Information revised 06/2026 (DailyMed)Prescribing Information revised 01/2025 (DailyMed)
Availability (site status, Oct 2026)Brand discontinuedMarketed

Main differences in plain words

  • Strattera (atomoxetine) contains atomoxetine; Qelbree contains viloxazine.
  • Form: Strattera (atomoxetine): capsule; Qelbree: extended-release capsule.
  • Controlled status: both: Not a controlled substance.
  • Generic: Strattera (atomoxetine): AB-rated generics; Qelbree: No generic.

What studies compare them

No direct comparison. No head-to-head trial of Strattera (atomoxetine) and Qelbree is in this site’s verified evidence base, so this page does not say that one works better than the other. Each product’s own page summarizes its placebo-controlled studies.

Switching between them (label)

What each FDA label says about starting it after another medicine. Switch the clinician view on to see the full label wording and any dose tables. More in the switching guide.

Strattera (atomoxetine): the label (section 2) gives no switching or conversion instruction. Section 2.6 covers only the 14-day gap when switching to or from an MAOI antidepressant.

Qelbree: the label (section 2) gives no switching or conversion instruction.

For clinicians

Label facts are from each product’s current prescribing information (Strattera (atomoxetine): revised 06/2026; Qelbree: revised 01/2025). Evidence summaries show the study detail and funding; comparative statements are limited to head-to-head trials, analyses of them and network meta-analyses. Indirect comparisons (for example, matching-adjusted indirect comparisons) are not used for efficacy claims.

Talk to your prescriber. These two medicines are not interchangeable at the same dose unless a label says so. Bring this page to your appointment if it helps, but do not change, stop or swap medicines on your own.

Frequently asked questions

What is the difference between Strattera (atomoxetine) and Qelbree?

Strattera (atomoxetine) contains atomoxetine (capsule); Qelbree contains viloxazine (extended-release capsule). Strattera (atomoxetine): Not a controlled substance. Qelbree: Not a controlled substance. The side-by-side table on this page lists approved ages, doses, duration and generic status from each label.

Is Strattera (atomoxetine) more effective than Qelbree?

No head-to-head trial of Strattera (atomoxetine) and Qelbree is in this site’s verified evidence base, so there is no direct evidence that one works better. Both are FDA-approved for ADHD in the ages shown on their labels.

Which lasts longer, Strattera (atomoxetine) or Qelbree?

Per the labels: Strattera (atomoxetine): Taken every day; the labels do not describe an hour-by-hour effect (benefit measured after weeks of treatment). Qelbree: Taken once daily, every day; the label does not describe hour-by-hour effects (benefit measured after 6–8 weeks). These figures come from separate label studies, not from one study comparing the two.

Can you switch from Strattera (atomoxetine) to Qelbree?

Neither label gives a milligram conversion between these two products. Strattera (atomoxetine) label: no switching or conversion instruction in section 2. Qelbree label: no switching or conversion instruction in section 2. Any switch is planned and adjusted by the prescriber.

Are Strattera (atomoxetine) and Qelbree available as generics?

Strattera (atomoxetine): AB-rated generics. Qelbree: No generic. Current supply is tracked on the availability tracker page.

Sources

  • Eli Lilly and Company. Strattera (atomoxetine) capsules. Prescribing Information, revised 06/2026. DailyMed (accessed Oct 2026).
  • Supernus Pharmaceuticals, Inc. Qelbree (viloxazine extended-release capsules). Prescribing Information, revised 01/2025. DailyMed; DailyMed version published Oct 08, 2026 (accessed Oct 2026).
EDUCATIONAL INFORMATION ONLY. Not medical advice. Medication decisions require individualized assessment by a qualified clinician. Do not start, stop, switch or change the dose of a medication without your prescriber. See the medical disclaimer.
Back to top